HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >
Graduate School of Medicine / Faculty of Medicine >
Peer-reviewed Journal Articles, etc >

Intravenous transplantation of amnion-derived mesenchymal stem cells promotes functional recovery and alleviates intestinal dysfunction after spinal cord injury

Files in This Item:

The file(s) associated with this item can be obtained from the following URL: https://doi.org/10.1371/journal.pone.0270606


Title: Intravenous transplantation of amnion-derived mesenchymal stem cells promotes functional recovery and alleviates intestinal dysfunction after spinal cord injury
Authors: Takamiya, Soichiro Browse this author
Kawabori, Masahito Browse this author →KAKEN DB
Yamazaki, Kazuyoshi Browse this author
Yamaguchi, Sho Browse this author
Tanimori, Aki Browse this author
Yamamoto, Koji Browse this author
Ohnishi, Shunsuke Browse this author
Seki, Toshitaka Browse this author
Konno, Kotaro Browse this author
Tha, Khin Khin Browse this author
Hashimoto, Daigo Browse this author
Watanabe, Masahiko Browse this author
Houkin, Kiyohiro Browse this author →KAKEN DB
Fujimura, Miki Browse this author →KAKEN DB
Issue Date: 8-Jul-2022
Publisher: PLOS
Journal Title: PLoS ONE
Volume: 17
Issue: 7
Start Page: e0270606
Publisher DOI: 10.1371/journal.pone.0270606
Abstract: Spinal cord injury (SCI) is often accompanied by gastrointestinal dysfunction due to the disconnection of the spinal autonomic nervous system. Gastrointestinal dysfunction reportedly upregulates intestinal permeability, leading to bacterial translocation of the gut microbiome to the systemic circulation, which further activates systemic inflammation, exacerbating neuronal damage. Mesenchymal stem cells (MSC) reportedly ameliorate SCI. Here, we aimed to investigate their effect on the associated gastrointestinal dysfunction. Human amnion-derived MSC (AMSCs) were intravenously transplanted one day after a rat model of midthoracic SCI. Biodistribution of transplanted cells, behavioral assessment, and histological evaluations of the spinal cord and intestine were conducted to elucidate the therapeutic effect of AMSCs. Bacterial translocation of the gut microbiome was examined by in situ hybridization and bacterial culture of the liver. Systemic inflammations were examined by blood cytokines, infiltrating immune cells in the spinal cord, and the size of the peripheral immune tissue. AMSCs released various neurotrophic factors and were mainly distributed in the liver and lung after transplantation. AMSC-transplanted animals showed smaller spinal damage and better neurological recovery with preserved neuronal tract. AMSCs transplantation ameliorated intestinal dysfunction both morphologically and functionally, which prevented translocation of the gut microbiome to the systemic circulation. Systemic inflammations were decreased in animals receiving AMSCs in the chronic phase. Intravenous AMSC administration during the acute phase of SCI rescues both spinal damage and intestinal dysfunction. Reducing bacterial translocation may contribute to decreasing systemic inflammation.
Type: article
URI: http://hdl.handle.net/2115/86980
Appears in Collections:医学院・医学研究院 (Graduate School of Medicine / Faculty of Medicine) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)

Export metadata:

OAI-PMH ( junii2 , jpcoar_1.0 )

MathJax is now OFF:


 

 - Hokkaido University